002422.SZ
002422.SZ
CNE100000PW7
KELUN PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 18.512.918.907 21.812.414.489
15.1%
Cost of Revenue 9.655.237.375 10.536.820.557
8.4%
Gross Profit 8.857.681.532 11.275.593.932
21.4%
6.368.751.246 6.909.096.307
7.8%
Operating Income 2.488.930.286 4.366.497.625
43.0%
Pretax Income 2.403.835.588 4.285.358.824
43.9%
Net Income Common Stockholders 1.701.935.493 2.935.892.103
42.0%
-- --
--
-- --
--
ende